Embryonic stem cells as source for endothelial cells for cell-based therapies

S. Becker, S. Liebner, W. Seeger, H. Sauer, W. Clauss, R. Voswinckel (Bad Nauheim, Frankfurt/Main, Giessen, Germany)

Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Session: Pathobiology of pulmonary hypertension
Session type: Thematic Poster Session
Number: 1096
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Becker, S. Liebner, W. Seeger, H. Sauer, W. Clauss, R. Voswinckel (Bad Nauheim, Frankfurt/Main, Giessen, Germany). Embryonic stem cells as source for endothelial cells for cell-based therapies. Eur Respir J 2010; 36: Suppl. 54, 1096

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021


Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Mesenchymal stem cells and their potential for clinical use
Source: Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung
Year: 2004

Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

Induced pluripotent stem cell derived macrophages differentiate into AM like cells in the lungs of humanized PAP mice
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017

Lung stem cells and the role of the stem cell niche
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021


Derivation of epithelial-only airway organoids from human pluripotent stem cells
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair
Source: ERS Lung Science Conference 2020
Year: 2020


3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Efficient gene transduction of adipose tissue-derived mesenchymal stem cells (MSCs) for asthma research
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011


Generation and Immunogenicity of induced pluripotent stem cells
Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases
Year: 2014

Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021